A. Menarini Pharmaceuticals Ireland Ltd has announced that Keral 25mg tablets (50-tablet pack) and Keral 25mg granules for oral solution (20-sachet pack) have been added to the list of prescribable medicinal products under the dental scheme. Keral tablets and Keral granules for oral solution are both indicated for the short-term symptomatic treatment of pain of mild to moderate intensity, such as dental pain and acute musculo-skeletal pain.
Keral tablets and Keral granules for oral solution contain Dexketoprofen Trometamol. Due to the solubility of the tromethamine salt in Keral there is rapid absorption that produces a greater plasma concentration of the drug in less time, which means a fast onset of action. The onset of the analgesic activity for both presentations of Keral was obtained in some studies at 30 minutes post administration. The analgesic effect persists for four to six hours.
The recommended dosage is 25mg od-tid, with the total daily dose not exceeding 75mg. For full prescribing information, please refer to www.medicines.ie.